Dana Edwards, MD
Surgery · Manchester, KYNPI 1164424131
Payments from drug & device makers
Across 198 payments — averaging $12.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$980
- Redhill Biopharma Inc.$423
- AbbVie$355
- Amgen$141
- Davol Inc.$131
- Takeda Pharmaceuticals U.S.A., Inc.$109
- plus $399 from 16 others
What the payments were for
- Food & beverage$2,538100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 98 | $980 |
| Redhill Biopharma Inc. | 43 | $423 |
| AbbVie(2 entities) | 17 | $355 |
| Amgen | 8 | $141 |
| Davol Inc. | 3 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $109 |
| Indivior Inc. | 4 | $82 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Biodelivery Sciences International, Inc. | 3 | $41 |
| Boston Scientific | 1 | $27 |
| Daiichi Sankyo Inc. | 2 | $25 |
| Philips North America LLC | 1 | $23 |
| Pfizer | 1 | $21 |
| Innocoll Pharmaceuticals Limited | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Medtronic | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
How this compares
$2,538 in reported general payments places this provider in the 50th percentile of 377 surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SymproicNaldemedine Tosylate | 12 | $6,369 |
| Ondansetron OdtOndansetron | 14 | $880 |
| Pantoprazole Sodium | 16 | $65 |
Paid to pharmacies, not to this prescriber.
Other surgery in Manchester
- Joseph KimLexington$1.6M
- John RothLexington$1.6M
- Eric SmithAshland$1.1M
- John OldhamLouisville$515K
- George MundayDanville$271K
- Amber KoonHenderson$210K
- George BushBowling Green$120K
- Frank MillerLouisville$119K
- David VictorMorehead$113K
- Jared DavisLouisville$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.